# Adversarial review log — rna-scaffold

- **Authoring model:** Sol 6.1
- **Adversarial reviewer:** Claude Opus 5.5 (Anthropic)
- **Date:** 2026-10-14
- **Canonical file:** `hsef_v53_final_nine_2026-10-12\rna-scaffold\rna-scaffold.review.md`
- **Level before → after:** Γ — Mechanistically plausible, partial system support → **Γ** (unchanged)
- **Confidence before → after:** Moderate → Moderate (band unchanged; rationale rescoped, see F5)
- **Causal role / M / S / D:** reinforcing / stabilizing factor · Mechanistic only · Stable · Contested (all unchanged)
- **PMIDs checked:** 66/66 resolved (60 references + 6 body-only); 0 failures, 0 retractions or expressions of concern
- **Load-bearing claims spot-checked:** 26 lettered sub-claims across 8 sources
- **Validator:** FAIL (1) — `v5.lay_summary` "no lay_summary; mandatory from v5.4", 33 checks pass. **Identical on the pre-edit file**, so this is a pre-existing v5.4-versus-v5.3 mismatch and not a regression. Output saved to `validator.txt`; the original package report is preserved at `sol61-original/validation-report.json`.

## Findings by severity

| Severity | Count |
|---|---|
| Critical | 0 |
| Major | 0 |
| Minor | 3 |
| Editorial | 2 |
| **Total corrections applied** | **5** |

## Findings table

| ID | Severity | Location | Correction | Evidence |
|---|---|---|---|---|
| F1 | Minor | Registered claim and scope; score card `index_rule_deviation` | The narrowing of SC1 relative to `hypothesis-index.md` is now declared in both artifacts; the deviation field had been left empty | The index states SC1 as the necessity-and-sufficiency claim for NEAT1, XIST and MATR3/LINE1; the review scores the narrower existential form. The narrowing is right on the evidence, but SKILL.md requires it to be stated and justified in both artifacts. Headline unaffected. |
| F2 | Minor | Item [15]; card [15]; Consensus reconciliation | "Long-isoform loss removes paraspeckles …" → "Neat1 loss, including the architectural long isoform, removes paraspeckles …" | PMID 21444682 targets the whole Neat1 gene; the earlier wording implied an isoform-selective allele the study did not make. |
| F3 | Editorial | Evidence section, reconciliation, final-score paragraph | "final2025" → "final 2025" (×3); "Step5" → "Step 5" | Missing-space rendering defect. |
| F4 | Editorial | Momentum artifact (review and score card) | "The 2025 SAF-A degron/domain work" → "The 2025 SAF-A depletion and domain-rescue work" | Internal consistency with card [5] and the reconciliation entry, which describe endogenous depletion plus near-endogenous rescue, not a degron. |
| F5 | Minor | Score card `final_score.confidence_rationale` | Rationale rested partly on "incomplete access" → rewritten to rest only on evidence density and reproducibility | The framework ties confidence to evidence density and reproducibility, not reviewer access. Band re-derived and **stays Moderate**: local RNA-compartment work replicates across cell systems and a mouse null allele, but the global claim rests on few structural studies sharing multifunctional-protein perturbations and extraction methods. |

Rejected findings — including the full aggregation re-derivation against the index entry, the SC1
Ζ threshold check, the competing-model set, the three unreferenced errata, the preprint pairs and
the partial-body claim audit — are recorded in the `## ADVERSARIAL REVIEW AND APPROVAL` section of
the review itself.

## Files changed in this case folder

- `rna-scaffold.review.md` — F1-F5, banner, `## ADVERSARIAL REVIEW AND APPROVAL`
- `rna-scaffold.scorecard.json` — F1 (`subclaim_matrix.index_rule_deviation` filled), F2-F5 mirrored (no level, confidence, subclaim level, aggregation rule or M/S/D value changed; CRLF line endings preserved)
- `CONSENSUS_CROSSCHECK.md` — F2, F3
- `validator.txt` — new
- `ADVERSARIAL_REVIEW.md`, `adversarial-findings.json` — new
- `sol61-original/` — pre-edit copies

## Propagation

The finished review and score card were copied byte-for-byte to
`hsef_v53_remaining_priority_16_19_2026-10-12\rna-scaffold\`, and the hashes were compared.

## Approval

Following adversarial review and the corrections listed above, the revised document is approved.
— Claude Opus 5.5 (Anthropic), 2026-10-14.